XANDER WEHRENS to Molecular Targeted Therapy
This is a "connection" page, showing publications XANDER WEHRENS has written about Molecular Targeted Therapy.
Connection Strength
0.160
-
Targeting pathological leak of ryanodine receptors: preclinical progress and the potential impact on treatments for cardiac arrhythmias and heart failure. Expert Opin Ther Targets. 2020 01; 24(1):25-36.
Score: 0.133
-
Serine/Threonine Phosphatases in Atrial Fibrillation. J Mol Cell Cardiol. 2017 02; 103:110-120.
Score: 0.027